1. Leuk Lymphoma. 2019 Mar;60(3):852-855. doi: 10.1080/10428194.2018.1509319.
Epub  2018 Sep 19.

Myelofibrosis patients can develop extramedullary complications including renal 
amyloidosis and sclerosing hematopoietic tumor while otherwise meeting 
traditional measures of ruxolitinib response.

Babushok DV(1)(2), Nelson EJ(3), Morrissette JJD(3), Joshi S(4), Palmer MB(3), 
Frank D(3), Cambor CL(3), Hexner EO(1).

Author information:
(1)a Department of Medicine, Division of Hematology-Oncology , Hospital of the 
University of Pennsylvania , Philadelphia , PA ; USA.
(2)b Department of Pediatrics, Comprehensive Bone Marrow Failure Center, 
Division of Hematology , Children's Hospital of Philadelphia , Philadelphia , PA 
, USA.
(3)c Department of Pathology and Laboratory Medicine , Hospital of the 
University of Pennsylvania , Philadelphia , PA , USA.
(4)d Department of Medicine, Division of Nephrology , Hospital of the University 
of Pennsylvania , Philadelphia , PA , USA.

DOI: 10.1080/10428194.2018.1509319
PMCID: PMC6424649
PMID: 30227762 [Indexed for MEDLINE]

Conflict of interest statement: Conflict of interest statement: The authors have 
no conflicts of interests to disclose.